Teva Pharmaceutical Industries (TEVA) Return on Assets (2016 - 2026)
Teva Pharmaceutical Industries (TEVA) posted Return on Assets of 0.0% for Q1 2026, up 10.44% on a QoQ basis from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.
Teva Pharmaceutical Industries (TEVA) Return on Assets (2016 - 2026) Analysis & Trends
Teva Pharmaceutical Industries' Return on Assets history runs 10 years deep, the most recent figure standing at 0.0% for Q1 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets was 0.0% for Q1 2026 at Teva Pharmaceutical Industries, up from 0.0% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.0% in Q4 2023.
- A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
- Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
- Teva Pharmaceutical Industries' Return on Assets stood at 0.0% in 2022, then decreased by 18 bps to 0.0% in 2023, then surged by 62 bps to 0.0% in 2024, then soared by 238 bps to 0.0% in 2025, then gained by 10 bps to 0.0% in 2026.
- Business Quant data shows TEVA's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 0.00% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.00% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |